Search Results - "Faez, L"

Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index by Carmona-Bayonas, A, Jiménez-Fonseca, P, Font, C, Fenoy, F, Otero, R, Beato, C, Plasencia, J M, Biosca, M, Sánchez, M, Benegas, M, Calvo-Temprano, D, Varona, D, Faez, L, de la Haba, I, Antonio, M, Madridano, O, Solis, M P, Ramchandani, A, Castañón, E, Marchena, P J, Martín, M, Ayala de la Peña, F, Vicente, V

“…Background: Our objective was to develop a prognostic stratification tool that enables patients with cancer and pulmonary embolism (PE), whether incidental or…”
Get full text

Analysis of bone events in patients with aromatase inhibitors (AI) by Arrojo, S.F., Garcia-Carús, E., Gómez, C., Rodriguez, P., Rivas, D., Faez, L., Iglesias Gomez, C., Izquierdo Manuel, M.E., Fernandez Perez, Y.

Get full text

On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism by Carmona-Bayonas, A, Font, C, Fonseca, P. Jiménez, Fenoy, Francisco, Otero, R, Beato, C, Plasencia, J, Biosca, M, Sánchez, M, Benegas, M, Calvo-Temprano, D, Varona, D, Faez, L, Vicente, M.A, de la Haba, I, Antonio, M, Madridano, O, Ramchandani, A, Castañón, E, Marchena, P.J, Martínez, M.J, Martín, M, Marín, G, de la Peña, F. Ayala, Vicente, V

“…Abstract Background Acute symptomatic pulmonary embolism (PE) varies in its clinical manifestations in patients with cancer and entails specific issues. The…”
Get full text

1947 Effect of oral cyclophosphamide use on pathologic complete response rate in theneoadjuvant treatment of breast cancer by Luque, M, Faez, L, Garcia-Teijido, P, Rodriguez-Rubi, D, Ruiz-Echeverria, L, Sanchez-Lorenzo, L, Li, W, Solis, P, Palacio, I, Fernandez-Perez, Y

Get full text

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer by Jiménez-Fonseca, P., Solis, M. P., Garrido, M., Faez, L., Rodriguez, D., Ruiz, A. L., Sanchez Lorenzo, M. L., Uriol, E., Menendez, M. D., Viéitez, J. M.

“…Purpose A proportion of patients with metastatic colorectal cancer (mCRC) are still able to continue with active therapy after their progression to…”
Get full text

The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism by Jiménez-Fonseca, P., Carmona-Bayonas, A., Font, C., Plasencia-Martínez, J., Calvo-Temprano, D., Otero, R., Beato, C., Biosca, M., Sánchez, M., Benegas, M., Varona, D., Faez, L., Antonio, M., de la Haba, I., Madridano, O., Solis, M. P., Ramchandani, A., Castañón, E., Marchena, P. J., Martín, M., de la Peña, F. Ayala, Vicente, V.

“…Aim To assess the prevalence and prognostic significance of additional intrathoracic findings (AIFs) in patients with cancer and pulmonary embolism (PE). AIFs…”
Get full text

C0269: Outpatient Management of Cancer-Related Pulmonary Embolism: Analysis of 562 Consecutive Patients from the Epiphany Study by Madridano, O, Carmona-Bayonas, A, Fonseca, P.J, Beato, C, Faez, L, Vicente, M.A, Biosca, M, Plasencia, J, Calvo-Temprano, D, Dominguez, A, Arguis, P, Font, C, Otero, R, Vicente, V

Get full text

C0271: Incidental Versus Symptomatic Pulmonary Embolism (PE) in Cancer Patients: Clinical Features and Short Term Outcomes of 562 Consecutive Patients from the Epiphany Study by Carmona-Bayonas, A, Font, C, Jiménez Fonseca, P, Beato, C, Faez, L, Angeles Vicente, M, Biosca, M, Madridano Cobo, O, Plasencia, J, Calvo Templado, D, Dominguez, A, Arguis Giménez, P, Otero Candelera, R, Vicente, V

Get full text

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer by Jiménez-Fonseca, P., Solis, M. P., Garrido, M., Faez, L., Rodriguez, D., Ruiz, A. L., Sanchez Lorenzo, M. L., Uriol, E., Menendez, M. D., Viéitez, J. M.

Get full text

CP-117 Use and effectiveness of firstline chemotherapy regimens in advanced gastric cancer: evolution from 2009 to 2016 by Manceñido, FJ Alvarez, Palomo, A Rodriguez, Garcia, I Zapico, de Prado, JM Vieitez, Lorenzo, ML Sanchez, Arrojo, S Fernandez, Garcia, L Faez, Hernandez, MP Solis, Jimenez-Fonseca, P, Carmona-Bayonas, A

“…BackgroundThere is neither consensus on firstline chemotherapy for advanced gastric cancer (AGC) nor new drugs or schemes approved in recent years.PurposeTo…”
Get full text

On sandwich results of univalent functions defined by a linear operator by AL-Ameedee, Sarah A., Atshan, Waggas Galib, Ali AL-Maamori, Faez

“…In the present paper, we obtain sandwich theorems for univalent functions by using some results of differential subordination and superordination for univalent…”
Get full text

1708PAnalysis of bone events in patients with aromatase inhibitors (AI) by Arrojo, S F, Garcia-Carús, E, Gómez, C, Rodriguez, P, Rivas, D, Faez, L, Iglesias Gomez, C, Izquierdo Manuel, M E, Fernandez Perez, Y

Get full text

975PmTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors by Suarez Rodriguez, C, Arranz Arija, J A, Morales Barrera, R, Puente, J, Reig, O, Faez, L, González del Alba, A, Valderrama, B P, Gallardo, E, Mellado, B, Esteban, E, Jimenez, J, Vivancos, A, Carles, J

“…Abstract Background Activation of the mTOR pathway is associated with shorter overall survival (OS) in patients (p) with metastatic renal cell carcinoma…”
Get full text

975P - mTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors by Suarez Rodriguez, C., Arranz Arija, J.A., Morales Barrera, R., Puente, J., Reig, O., Faez, L., González del Alba, A., Valderrama, B.P., Gallardo, E., Mellado, B., Esteban, E., Jimenez, J., Vivancos, A., Carles, J.

“…Activation of the mTOR pathway is associated with shorter overall survival (OS) in patients (p) with metastatic renal cell carcinoma (mRCC). This outcome could…”
Get full text

mTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors by Suarez Rodriguez, C., Arranz Arija, J.A., Morales Barrera, R., Puente, J., Reig, O., Faez, L., González del Alba, A., Valderrama, B.P., Gallardo, E., Mellado, B., Esteban, E., Jimenez, J., Vivancos, A., Carles, J.

Get full text

TERT as a prognostic factor for gliomas progression-free survival (PFS) by Hernandez, M.P. Solis, Faez, L., Cantero, D., Lain, A. Hernandez, Gomez, P. Sanchez, Ruano, Y., Galera, M.D.M., Sánchez, J.M. Sepúlveda

Get full text

Counting Functions to Generate The Primes in the RSA Algorithm and Diffie-Hellman Key Exchange by AL-Maamori, Faez Ali, Rashid, Mazin Saied

“…        The Rivest–Shamir–Adleman (RSA) and the Diffie-Hellman (DH) key exchange are famous methods for encryption. These methods  depended on selecting…”
Get full text

Outpatient management of cancer-associated pulmonary embolism (PE): analysis of lung carcinoma (LC) cohort from the Epiphany study by Beato, C., Faez, L., Carmona-Bayonas, A., Mediano, M.D., Font, C., Calvo-Temprano, D., Fonseca, P. Jimenez, Dominguez, A., Hernandez, M.P. Solis, Biosca, M., Haba, Idela, Antonio, M., Madriano, O., Ramchandani, A., Alvarez, E. Castanon, Martinez, M.J., Echaburu, J.A. Virizuela, Otero, R.

Get full text

Outpatient Management of Cancer-Related Pulmonary Embolism: a Propensity Score-Matched Analysis of 803 Patients from the Epiphany Study by Carmona-Bayonas, A., Biosca, M., Puig, C. Font, Faez, L., Solís Hernández, M.D.P., Jimenez Fonseca, P., Antonio Rebollo, M., De La Haba, I., Castanon Alvarez, E., Beato, C., Ramchandani, A., Vicente Conesa, M.A., Madridano, O., Otero, R.

Get full text

1485PDOUTPATIENT MANAGEMENT OF CANCER-RELATED PULMONARY EMBOLISM: A PROPENSITY SCORE-MATCHED ANALYSIS OF 803 PATIENTS FROM THE EPIPHANY STUDY by Carmona-Bayonas, A., Biosca, M., Puig, C. Font, Faez, L., Solís Hernández, M.D.P., Jimenez Fonseca, P., Antonio Rebollo, M., De La Haba, I., Castanon Alvarez, E., Beato, C., Ramchandani, A., Vicente Conesa, M.A., Madridano, O., Otero, R.

“…Abstract Aim: Outpatient management of ‘low-risk’ pulmonary embolism (PE) is suggested in clinical guidelines (Evidence 2B) although the definition of…”
Get full text